eDiabetes Review
Risks and Benefits of SGLT-2 Inhibitor Agents
June 30, 2016
Volume 2, Issue 11. Anne Peters, MD covers the important topic of Risks and Benefits of SGLT-2 Inhibitor Agents in the format of case-study scenarios for the clinical practice.
New York
EDiabetes Review podcast channel
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast